It is time for more colors!

Retinal drawing with a color-coding system brings uniformity in representation of fundus findings so that clinician can decipher various lesions on a two-dimensional drawing. Existing color coding addresses most of the common retinal pathologies including preretinal, intraretinal, and subretinal lesions. However, with the advent of various imaging modalities there is deeper understanding of microanatomy of retina and associated pathologies. With this, there appears further need of newer set of color coding to include the minute details of fundus findings clinically. Through this article, we discuss few common pathologies at different levels of retina layers with color-coding dilemma which calls for a better preciseness in its clinical representations

Effect of lanosterol on human cataract nucleus.

Aim: To study the effect of lanosterol on age‑related cataractous human lens nuclei. Materials and Methods: Forty age‑related cataractous nuclei removed during manual small incision cataract surgery were obtained and randomly immersed in 25 mM lanosterol solution or in control solution and stored at room temperature for 6 days. Pre‑ and post‑immersion photographs were graded by two masked observers and collated for the regression or progression of lens opacity. Results: Both lanosterol and control groups showed progression or no change in the lens opacity at the end of 6 days. Conclusion: Lanosterol 25 mM solution did not reverse opacification of human age‑related cataractous nuclei.

Sutureless scleral buckle in the management of rhegmatogenous retinal detachment.

Purpose: To evaluate the anatomical and functional outcomes of sutureless scleral buckling for the repair of rhegmatogenous retinal detachment (RD). Design: Retrospective interventional case series. Materials and Methods: Retrospective analysis of 50 eyes of 49 patients with rhegmatogenous RD, who underwent sutureless scleral buckling from January 2009 to March 2013. Results: Primary retinal re‑attachment rate of 86% was achieved with single surgery, but final anatomical success was 94% with additional interventions in the form of intravitreal gas, buckle revision, and/or pars plana vitrectomy. Best corrected logarithm of minimum angle of resolution visual acuity improved from 1.44 ± 1.01 preoperatively to 0.50 ± 0.40 at a mean follow‑up of 6.7 months. Conclusion: Sutureless scleral buckling achieves excellent anatomical and functional success in majority of the patients with rhegmatogenous RD.

Vascular tumors of the choroid and retina.

Vascular tumors of the retina and choroid can be seen occasionally. In the following article, the key clinical and diagnostic features of the major retinal and choroidal vascular tumors, their systemic associations, and the literature pertaining to the most currently available treatment strategies are reviewed.

Changing paradigms of anti-VEGF in the Indian scenario.

Anti-vascular endothelial growth factors (VEGF) agents have revolutionized the treatment of retinal diseases. Use of anti-VEGF agents in the Indian Scenario present some unique challenges considering the absence of compounding pharmacies, poor penetrance of health insurance and limited aff ordability of the citizens of a developing economy. To study the changing paradigms of anti-VEGF use in the Indian scenario, all articles published by Indian authors, data from web-based surveys amongst Indian vitreo-retinal specialists were reviewed. In the paucity of compounding pharmacies in India, fractionation and injection techniques diff er from those of developed countries. Frequent anti-VEGF monotherapy off ers the best anatomical and visual results, but economics of scale do not allow the same in the Indian scenario, resulting in PRN dosing and combination of anti-VEGF with laser photocoagulation, being the commonly employed treatment protocols.